Published on 25.04.18 in Vol 7, No 4 (2018): April
Works citing "Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis"
According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.9024):
(note that this is only a small subset of citations)
- Morgante G, Cappelli V, Troìa L, De Leo V. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome. The European Journal of Contraception & Reproductive Health Care 2020;:1CrossRef
- Landersoe SK, Larsen EC, Forman JL, Birch Petersen K, Kroman MS, Frederiksen H, Juul A, Nøhr B, Løssl K, Nielsen HS, Nyboe Andersen A. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH?. Gynecological Endocrinology 2020;:1CrossRef
- Skiba MA, Islam RM, Bell RJ, Davis SR. Hormonal contraceptive use in Australian women: Who is using what?. Australian and New Zealand Journal of Obstetrics and Gynaecology 2019;59(5):717CrossRef